These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 11102253)

  • 1. A randomized placebo-controlled trial to assess the efficacy of antiinflammatory therapy with methylprednisolone in unstable angina (MUNA trial).
    Azar RR; Rinfret S; Théroux P; Stone PH; Dakshinamurthy R; Feng YJ; Wu AH; Rangé G; Waters DD
    Eur Heart J; 2000 Dec; 21(24):2026-32. PubMed ID: 11102253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and preliminary efficacy of one month glycoprotein IIb/IIIa inhibition with lefradafiban in patients with acute coronary syndromes without ST-elevation; a phase II study.
    Akkerhuis KM; Neuhaus KL; Wilcox RG; Vahanian A; Boland JL; Hoffmann J; Baardman T; Nehmiz G; Roth U; Klootwijk AP; Deckers JW; Simoons ML;
    Eur Heart J; 2000 Dec; 21(24):2042-55. PubMed ID: 11102255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme; rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease.
    Mehta SR; Yusuf S;
    Eur Heart J; 2000 Dec; 21(24):2033-41. PubMed ID: 11102254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of pravastatin compared with placebo initiated within 24 hours of onset of acute myocardial infarction or unstable angina: the Pravastatin in Acute Coronary Treatment (PACT) trial.
    Thompson PL; Meredith I; Amerena J; Campbell TJ; Sloman JG; Harris PJ;
    Am Heart J; 2004 Jul; 148(1):e2. PubMed ID: 15215811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative efficacy of once daily parnaparin and unfractionated heparin in unstable angina pectoris: PRIME CARE study.
    PRIME CARE Study Investigators Group
    Indian Heart J; 2005; 57(6):648-54. PubMed ID: 16521631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atorvastatin has an important acute anti-inflammatory effect in patients with acute coronary syndrome: results of a randomized, double-blind, placebo-controlled study.
    Macin SM; Perna ER; Farías EF; Franciosi V; Cialzeta JR; Brizuela M; Medina F; Tajer C; Doval H; Badaracco R
    Am Heart J; 2005 Mar; 149(3):451-7. PubMed ID: 15864233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rovamycine as add-on treatment in unstable angina and 4 year evolution with major cardiovascular events.
    Rădoi M; Bobescu E; Agache I
    Rom J Intern Med; 2003; 41(3):237-46. PubMed ID: 15526507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of prednisolone on local and systemic response in laparoscopic vs. open colon surgery: a randomized, double-blind, placebo-controlled trial.
    Vignali A; Di Palo S; Orsenigo E; Ghirardelli L; Radaelli G; Staudacher C
    Dis Colon Rectum; 2009 Jun; 52(6):1080-8. PubMed ID: 19581850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inflammation study in unstable angina and myocardial infarction without ST segment elevation. Value of ultra-sensitive C-reactive protein].
    Borrás Pallé S; Gómez Martínez E; Romero Rodrigo A; Campos Ferrer C; Molina E; Valentín Segura V
    An Med Interna; 2002 Jun; 19(6):283-8. PubMed ID: 12152386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial.
    Patti G; Pasceri V; Colonna G; Miglionico M; Fischetti D; Sardella G; Montinaro A; Di Sciascio G
    J Am Coll Cardiol; 2007 Mar; 49(12):1272-8. PubMed ID: 17394957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.
    Silver M; Corwin MJ; Bazan A; Gettinger A; Enny C; Corwin HL
    Crit Care Med; 2006 Sep; 34(9):2310-6. PubMed ID: 16878035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A blinded, randomized, placebo-controlled trial of percutaneous laser myocardial revascularization to improve angina symptoms in patients with severe coronary disease.
    Leon MB; Kornowski R; Downey WE; Weisz G; Baim DS; Bonow RO; Hendel RC; Cohen DJ; Gervino E; Laham R; Lembo NJ; Moses JW; Kuntz RE
    J Am Coll Cardiol; 2005 Nov; 46(10):1812-9. PubMed ID: 16286164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasopressin, epinephrine, and corticosteroids for in-hospital cardiac arrest.
    Mentzelopoulos SD; Zakynthinos SG; Tzoufi M; Katsios N; Papastylianou A; Gkisioti S; Stathopoulos A; Kollintza A; Stamataki E; Roussos C
    Arch Intern Med; 2009 Jan; 169(1):15-24. PubMed ID: 19139319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefit of clopidogrel according to timing of percutaneous coronary intervention in patients with acute coronary syndromes: further results from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study.
    Lewis BS; Mehta SR; Fox KA; Halon DA; Zhao F; Peters RJ; Keltai M; Budaj A; Yusuf S;
    Am Heart J; 2005 Dec; 150(6):1177-84. PubMed ID: 16338255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
    Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
    Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose statin and COX-2 inhibitor therapy rapidly decreases C-reactive protein level in patients with unstable angina.
    Chyrchel M; Dudek D; Bartuś S; Legutko J; Heba G; Dubiel JS
    Kardiol Pol; 2004 Sep; 61(9):213-21; discussion 222-4. PubMed ID: 15531933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and biochemical results of the metalloproteinase inhibition with subantimicrobial doses of doxycycline to prevent acute coronary syndromes (MIDAS) pilot trial.
    Brown DL; Desai KK; Vakili BA; Nouneh C; Lee HM; Golub LM
    Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):733-8. PubMed ID: 14962945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, controlled study of a single intra-articular injection of etanercept or glucocorticosteroids in patients with rheumatoid arthritis.
    Bliddal H; Terslev L; Qvistgaard E; Konig M; Holm CC; Rogind H; Boesen M; Danneskiold-Samsøe B; Torp-Pedersen S
    Scand J Rheumatol; 2006; 35(5):341-5. PubMed ID: 17062431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized comparison of the effects of ASA plus clopidogrel versus ASA alone on early platelet activation in acute coronary syndromes with elevated high-sensitivity C-reactive protein and soluble CD40 ligand levels.
    Vavuranakis M; Latsios G; Aggelis D; Bosinakou I; Karambelas I; Tousoulis D; Toutouzas K; Stefanadis C
    Clin Ther; 2006 Jun; 28(6):860-71. PubMed ID: 16860169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of sirolimus-eluting stenting and its effect on restenosis in patients with unstable angina pectoris (a SIRIUS substudy).
    Weisz G; Moses JW; Teirstein PS; Holmes DR; Raizner AE; Satler LF; Mishkel G; Wilensky RL; Wang P; Kuntz RE; Popma JJ; Leon MB
    Am J Cardiol; 2007 Apr; 99(8):1044-50. PubMed ID: 17437725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.